SIMCERE PHARMACEUTICAL GROUP's ticker is SCR and the CUSIP is 82859P104. A total of 2 filers reported holding SIMCERE PHARMACEUTICAL GROUP in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2012 | $804,000 | -8.6% | 100,000 | 0.0% | 0.03% | -11.1% |
| Q3 2012 | $880,000 | -2.0% | 100,000 | 0.0% | 0.04% | -10.0% |
| Q2 2012 | $898,000 | -4.9% | 100,000 | 0.0% | 0.04% | -7.0% |
| Q1 2012 | $944,000 | +0.4% | 100,000 | 0.0% | 0.04% | 0.0% |
| Q4 2011 | $940,000 | – | 100,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 100,000 | $940,000 | 0.04% |
| Mirae Asset Global Investments Co., Ltd. | 12,731 | $120,000 | 0.01% |